title: Impact of deleterious passenger mutations on cancer progression.
abstract: Cancer progression is driven by the accumulation of a small number of genetic alterations. However, these few driver alterations reside in a cancer genome alongside tens of thousands of additional mutations termed passengers. Passengers are widely believed to have no role in cancer, yet many passengers fall within protein-coding genes and other functional elements that can have potentially deleterious effects on cancer cells. Here we investigate the potential of moderately deleterious passengers to accumulate and alter the course of neoplastic progression. Our approach combines evolutionary simulations of cancer progression with an analysis of cancer sequencing data. From simulations, we find that passengers accumulate and largely evade natural selection during progression. Although individually weak, the collective burden of passengers alters the course of progression, leading to several oncological phenomena that are hard to explain with a traditional driver-centric view. We then tested the predictions of our model using cancer genomics data and confirmed that many passengers are likely damaging and have largely evaded negative selection. Finally, we use our model to explore cancer treatments that exploit the load of passengers by either (i) increasing the mutation rate or (ii) exacerbating their deleterious effects. Though both approaches lead to cancer regression, the latter is a more effective therapy. Our results suggest a unique framework for understanding cancer progression as a balance of driver and passenger mutations.
authors: Graduate Program in Biophysics, Harvard University, Boston, MA 02115, USA.
authors: Christopher D
authors: CD
authors: McFarland
authors: Kirill S
authors: KS
authors: Korolev
authors: Gregory V
authors: GV
authors: Kryukov
authors: Shamil R
authors: SR
authors: Sunyaev
authors: Leonid A
authors: LA
authors: Mirny
mesh_terms: D018450:Disease Progression; D019143:Evolution, Molecular; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology*
references: PLoS Comput Biol. 2006 Aug 18;2(8):e108
references: 16933983
references: Br J Cancer. 1964 Sep;13:490-502
references: 14219541
references: Cancer Res. 2010 Oct 15;70(20):8149-58
references: 20736363
references: Nature. 2012 May 09;485(7399):502-6
references: 22622578
references: Br J Cancer. 1966 Sep;20(3):582-7
references: 5950880
references: Nature. 2010 Feb 18;463(7283):899-905
references: 20164920
references: Cell. 2011 Aug 19;146(4):633-44
references: 21854987
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
references: 20876136
references: Science. 2011 Aug 19;333(6045):1026-30
references: 21852501
references: Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2873-8
references: 8610134
references: Lancet Oncol. 2002 Aug;3(8):487-97
references: 12147435
references: Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557
references: 18483233
references: Nat Rev Cancer. 2004 Mar;4(3):177-83
references: 14993899
references: J Invest Dermatol. 2006 Jan;126(1):32-41
references: 16417215
references: Cancer Res. 2011 May 15;71(10):3447-52
references: 21270108
references: Rev Mod Phys. 2010 Jun 1;82(2):1691-1718
references: 21072144
references: Nature. 2010 Jan 14;463(7278):191-6
references: 20016485
references: PLoS Comput Biol. 2007 Nov;3(11):e225
references: 17997597
references: Genetics. 2008 May;179(1):603-20
references: 18493075
references: Phys Biol. 2012;9(2):026008
references: 22476106
references: Science. 2008 Sep 26;321(5897):1807-12
references: 18772396
references: Genetics. 2011 Jun;188(2):383-93
references: 21441214
references: Science. 2006 Oct 13;314(5797):268-74
references: 16959974
references: Genetics. 1974 Oct;78(2):737-56
references: 4448362
references: Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18378-83
references: 22042860
references: Nat Biotechnol. 2011 Nov 20;29(12):1109-13
references: 22101486
references: Cell. 2007 Sep 21;130(6):1005-18
references: 17889646
references: Cancer Cell. 2011 Sep 13;20(3):400-13
references: 21907929
references: PLoS Genet. 2008 May 30;4(5):e1000083
references: 18516229
references: Mutat Res. 2000 Nov 30;456(1-2):65-71
references: 11087897
references: Carcinogenesis. 2010 Jan;31(1):27-36
references: 19752007
references: Nat Genet. 1992 Dec;2(4):318-23
references: 1303287
references: Genetics. 2006 Apr;172(4):2557-66
references: 16636113
references: Genetics. 2012 Aug;191(4):1283-93
references: 22649084
references: Nature. 2010 Jan 14;463(7278):184-90
references: 20016488
references: Oncotarget. 2011 Mar;2(3):209-21
references: 21444945
references: J Hered. 1993 Sep-Oct;84(5):339-44
references: 8409355
references: Protein Eng. 1999 May;12(5):387-94
references: 10360979
references: Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):680-5
references: 21187411
references: Cancer Res. 2004 May 15;64(10):3414-27
references: 15150093
references: Nature. 2011 Mar 24;471(7339):467-72
references: 21430775
references: Nature. 2008 Nov 6;456(7218):66-72
references: 18987736
references: Genetics. 2005 Dec;171(4):2123-31
references: 16143627
references: Genetics. 2000 Dec;156(4):2137-40
references: 11187462
references: Genetics. 2007 Dec;177(4):2209-21
references: 18073428
references: Genetics. 2012 Feb;190(2):753-79
references: 22135349
references: Cell Cycle. 2006 Aug;5(16):1740-3
references: 16929164
references: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4008-13
references: 17360468
references: Theor Popul Biol. 1978 Oct;14(2):251-67
references: 746491
references: Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16251-6
references: 15528276